Literature DB >> 19604300

mTOR: taking cues from the immune microenvironment.

Greg M Delgoffe1, Jonathan D Powell.   

Abstract

The ultimate outcome of T cell receptor recognition is determined by the context in which the antigen is encountered. In this fashion both antigen-presenting cells and T cells must integrate multiple environmental cues in the form of pathogen-associated molecular patterns, cytokines and accessory molecule signals. The mammalian target of rapamycin (mTOR) is an evolutionarily conserved serine/threonine kinase that plays a central role in integrating environmental signals critical to regulating metabolism and cell survival. In this paper we review the data demonstrating that mTOR integrates signals from the immune microenvironment and therefore facilitates the generation of the adaptive immune response. Specifically, we review the role of mTOR in promoting dendritic cell activation and maturation, in regulating full T cell activation versus anergy, and influencing the induction of regulatory T cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19604300      PMCID: PMC2729523          DOI: 10.1111/j.1365-2567.2009.03125.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  64 in total

Review 1.  Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance.

Authors:  Ralph Marvin Steinman; Michel C Nussenzweig
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-02       Impact factor: 11.205

2.  The danger model: a renewed sense of self.

Authors:  Polly Matzinger
Journal:  Science       Date:  2002-04-12       Impact factor: 47.728

Review 3.  Toll-like receptors and acquired immunity.

Authors:  Chandrashekhar Pasare; Ruslan Medzhitov
Journal:  Semin Immunol       Date:  2004-02       Impact factor: 11.130

Review 4.  Activation of dendritic cells: translating innate into adaptive immunity.

Authors:  Caetano Reis e Sousa
Journal:  Curr Opin Immunol       Date:  2004-02       Impact factor: 7.486

5.  Rapamycin inhibits IL-4--induced dendritic cell maturation in vitro and dendritic cell mobilization and function in vivo.

Authors:  Holger Hackstein; Timucin Taner; Alan F Zahorchak; Adrian E Morelli; Alison J Logar; Andre Gessner; Angus W Thomson
Journal:  Blood       Date:  2003-01-16       Impact factor: 22.113

Review 6.  TOR signaling.

Authors:  Thurl E Harris; John C Lawrence
Journal:  Sci STKE       Date:  2003-12-09

7.  Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton.

Authors:  D D Sarbassov; Siraj M Ali; Do-Hyung Kim; David A Guertin; Robert R Latek; Hediye Erdjument-Bromage; Paul Tempst; David M Sabatini
Journal:  Curr Biol       Date:  2004-07-27       Impact factor: 10.834

8.  The novel cyclophilin binding compound, sanglifehrin A, disassociates G1 cell cycle arrest from tolerance induction.

Authors:  Amy Allen; Yan Zheng; Lawrence Gardner; Meredith Safford; Maureen R Horton; Jonathan D Powell
Journal:  J Immunol       Date:  2004-04-15       Impact factor: 5.422

9.  Rapamycin specifically interferes with GM-CSF signaling in human dendritic cells, leading to apoptosis via increased p27KIP1 expression.

Authors:  Andrea M Woltman; Sandra W van der Kooij; Paul J Coffer; Rienk Offringa; Mohamed R Daha; Cees van Kooten
Journal:  Blood       Date:  2002-09-26       Impact factor: 22.113

10.  Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.

Authors:  WanJun Chen; Wenwen Jin; Neil Hardegen; Ke-Jian Lei; Li Li; Nancy Marinos; George McGrady; Sharon M Wahl
Journal:  J Exp Med       Date:  2003-12-15       Impact factor: 14.307

View more
  49 in total

Review 1.  How tolerogenic dendritic cells induce regulatory T cells.

Authors:  Roberto A Maldonado; Ulrich H von Andrian
Journal:  Adv Immunol       Date:  2010       Impact factor: 3.543

2.  Changing the energy of an immune response.

Authors:  Meghan M Delmastro-Greenwood; Jon D Piganelli
Journal:  Am J Clin Exp Immunol       Date:  2013-02-27

Review 3.  The mammalian target of rapamycin: linking T cell differentiation, function, and metabolism.

Authors:  Jonathan D Powell; Greg M Delgoffe
Journal:  Immunity       Date:  2010-09-24       Impact factor: 31.745

4.  Rapamycin Prevents Surgery-Induced Immune Dysfunction in Patients with Bladder Cancer.

Authors:  Robert S Svatek; Niannian Ji; Essel de Leon; Neelam Z Mukherjee; Aashish Kabra; Vincent Hurez; Marlo Nicolas; Joel E Michalek; Martin Javors; Karen Wheeler; Z Dave Sharp; Carolina B Livi; Zhen-Ju Shu; David Henkes; Tyler J Curiel
Journal:  Cancer Immunol Res       Date:  2018-12-18       Impact factor: 11.151

5.  Multifaceted regulation of T cells by CD44.

Authors:  Bas Jg Baaten; Cheng-Rui Li; Linda M Bradley
Journal:  Commun Integr Biol       Date:  2010-11-01

Review 6.  Metabolic control of the Treg/Th17 axis.

Authors:  Joseph Barbi; Drew Pardoll; Fan Pan
Journal:  Immunol Rev       Date:  2013-03       Impact factor: 12.988

7.  Hepatic stellate cells increase the immunosuppressive function of natural Foxp3+ regulatory T cells via IDO-induced AhR activation.

Authors:  Sudhir Kumar; Jiang Wang; Angus W Thomson; Chandrashekhar R Gandhi
Journal:  J Leukoc Biol       Date:  2016-08-31       Impact factor: 4.962

Review 8.  Induction and stability of the anergic phenotype in T cells.

Authors:  Rut Valdor; Fernando Macian
Journal:  Semin Immunol       Date:  2013-11-05       Impact factor: 11.130

Review 9.  Altered metabolic pathways regulate synovial inflammation in rheumatoid arthritis.

Authors:  U Fearon; M M Hanlon; S M Wade; J M Fletcher
Journal:  Clin Exp Immunol       Date:  2018-11-11       Impact factor: 4.330

Review 10.  mTOR, metabolism, and the regulation of T-cell differentiation and function.

Authors:  Adam T Waickman; Jonathan D Powell
Journal:  Immunol Rev       Date:  2012-09       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.